본문 바로가기
KERD
논문KCI 등재

Allogeneic Blood Transfusion Given Before Radiotherapy Is Associated with the Poor Clinical Outcome in Patients with Cervical Cancer

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose: To analyze the effect of allogeneic blood transfusion on clinical outcome in 119 patients with stage IIB cervical cancer who were treated with radiotherapy±chemotherapy. Patients and Methods: Medical records were examined for hemoglobin levels before and during radiotherapy, history of allogeneic blood transfusions and the time point when transfusions were given. These factors were retrospectively analyzed along with other clinical risk factors for influences on the patients’ clinical outcomes. Results: Thirty-two patients (26.9%) received packed red blood cell transfusion (mean, 3.4 units; range, 1-12 units) before or during radiotherapy. Median follow-up period was 39.3 months (range, 7.6-58.4 months). Patients with history of transfusion showed poorer metastasis- free survival and a trend toward poorer overall survival than non-transfused patients. When patients who received transfusions were sub-divided by the time of transfusion, those who received transfusions before radiotherapy had significantly poorer clinical outcome than those who received transfusions during radiotherapy. In a multivariable analysis, patients with pretreatment transfusion showed a higher risk of distant metastasis (HR=3.75, 95% CI: 1.28-12.15, p=0.017) and decreased overall survival rates (HR=4.62, 95% CI: 1.15-18.54, p=0.031) compared with those of other patients. Conclusion: Our results suggest that allogeneic blood transfusions given before radiotherapy may be associated with higher incidence of distant metastases and decreased survival in patients with stage IIB cervical cancer.

Abstract

Purpose: To analyze the effect of allogeneic blood transfusion on clinical outcome in 119 patients with stage IIB cervical cancer who were treated with radiotherapy±chemotherapy. Patients and Methods: Medical records were examined for hemoglobin levels before and during radiotherapy, history of allogeneic blood transfusions and the time point when transfusions were given. These factors were retrospectively analyzed along with other clinical risk factors for influences on the patients’ clinical outcomes. Results: Thirty-two patients (26.9%) received packed red blood cell transfusion (mean, 3.4 units; range, 1-12 units) before or during radiotherapy. Median follow-up period was 39.3 months (range, 7.6-58.4 months). Patients with history of transfusion showed poorer metastasis- free survival and a trend toward poorer overall survival than non-transfused patients. When patients who received transfusions were sub-divided by the time of transfusion, those who received transfusions before radiotherapy had significantly poorer clinical outcome than those who received transfusions during radiotherapy. In a multivariable analysis, patients with pretreatment transfusion showed a higher risk of distant metastasis (HR=3.75, 95% CI: 1.28-12.15, p=0.017) and decreased overall survival rates (HR=4.62, 95% CI: 1.15-18.54, p=0.031) compared with those of other patients. Conclusion: Our results suggest that allogeneic blood transfusions given before radiotherapy may be associated with higher incidence of distant metastases and decreased survival in patients with stage IIB cervical cancer.

참고문헌 (31)

  1. Fyles AW, "Anemia, hypoxia and transfusion in patients with cervix cancer: a review", Radiother Oncol, 57, pp.13~19 (2000)
  2. "Cancer Radiother", 2005, 87~95
  3. Vaupel P, "Oxygenation status of gynecologic tumors: what is the optimal hemoglobin level?", Strahlenther Onkol, 178, pp.727~731 (2002)
  4. Varlotto J, "Anemia, tumor hypoxemia, and the cancer patient", Int J Radiat Oncol Biol Phys, 63, pp.25~36 (2005)
  5. Koukourakis MI, "Hypoxiaactivated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer", Int J Radiat Oncol Biol Phys, 59, pp.67~71 (2004)
  6. Dunst J, "Management of anemia in patients undergoing curative radiotherapy. Erythropoietin, transfusions, or better nothing?", Strahlenther Onkol, 180, pp.671~681 (2004)
  7. Obermair A, "Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: Effect on progression-free survival", Int J Gynecol Cancer, 13, pp.633~639 (2003)
  8. Lavey RS, ". Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study", Gynecol Oncol, 95, pp.145~151 (2004)
  9. Wun T, "Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin", Cancer, 98, pp.1514~1520 (2003)
  10. Günter P, "Practice guidelines for blood component therapy", Anesthesiology, 85, pp.1219~1220 (1996)
  11. Birgegård G, "New guidelines on anaemia management in patients with cancer: How do these affect clinical practice?", Oncology, 69(2), pp.17~21 (2005)
  12. Murphy MF, "Guidelines for the clinical use of red cell transfusions", Br J Haematol, 113, pp.24~31 (2001)
  13. Okuno K, "Effect of packed red cell and whole blood transfusion on liver-associated immune function", Am J Surg, 168, pp.340~344 (1994)
  14. Clarke PJ, "Allogeneic blood transfusion reduces murine pulmonary natural killer (NK) activity and enhances lung metastasis of a syngeneic tumour", Int J Cancer, 55, pp.996~1002 (1993)
  15. Blajchman MA, "Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms", Vox Sang, 74(2), pp.315~319 (1998)
  16. Blajchman MA, "Transfusion immunomodulation or TRIM: what does it mean clinically?", Hematology, 10(1), pp.208~214 (2005)
  17. Yamamoto J, "Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy", Surgery, 115, pp.303~309 (1994)
  18. Tefferi A, "Anemia in adults: a contemporary approach to diagnosis", Mayo Clin Proc, 78, pp.1274~1280 (2003)
  19. Kwok JC, "The iron metabolism of neoplastic cells: alterations that facilitate proliferation?", Crit Rev Oncol Hematol, 42, pp.65~78 (2002)
  20. Clifton KH, "Mammary carcinoma cell population growth in preirradiated and unirradiated transplant sites. Viable tumor growth, vascularity, and the tumor-bed effect", Radiology, 117, pp.459~465 (1975)
  21. Zips D, "Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse", Int J Radiat Biol, 77, pp.1185~1193 (2001)
  22. Petersen C, "Impact of preirradiation of the tumour bed on cell production rate and cell loss of human FaDu squamous cell carcinoma growing in nude mice", Int J Radiat Biol, 75, pp.1293~1297 (1999)
  23. Kaminski JM, "controversial abscopal effect", Cancer Treat Rev, 31, pp.159~172 (2005)
  24. Demaria S, "Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated", Int J Radiat Oncol Biol Phys, 58, pp.862~870 (2004)
  25. Santin AD, "Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10", Int J Radiat Oncol Biol Phys, 54, pp.1345~1355 (2002)
  26. Quigley RL, "The effect of leukocytes on adhesionmolecules. An explanation of blood transfusion enhancement of tumor growth", Arch Surg, 131, pp.438~441 (1996)
  27. zur Hausen H, "Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers", Cancer Res, 49, pp.4677~4681 (1989)
  28. Yang HJ, "Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer", Int J Gynecol Cancer, 14, pp.903~910 (2004)
  29. Nagai Y, "Persistence of human papillomavirus infection as a predictor for recurrence in carcinoma of the cervix after radiotherapy", Am J Obstet Gynecol, 191, pp.1907~1913 (2004)
  30. Hill GE, "Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis", J Trauma, 54, pp.908~914 (2003)
  31. Bilgin YM, "Double-blind, randomized controlled trial on the effect of leukocytedepleted erythrocyte transfusions in cardiac valve surgery", Circulation, 109, pp.2755~2760 (2004)

관련 논문AI추천

Impact of hematologic toxicities during concurrent chemoradiation for cervical cancerAlison K. Yoder, Claire Mach, Feiya Shi, Matthew L Anderson, Michelle S Ludwig, Shraddha Dalwadi, Tracilyn R Hall대한산부인과학회 · Obstetrics & Gynecology Science2022 · 제65권 제2호Impact of Chemoradiation on Prognosis in Stage IVB Cervical Cancer with Distant Lymphatic Metastasis김재원, 김태헌, 김학재, 김희승, 박노현, 송용상, 이응석, 정현훈대한암학회 · Cancer Research and Treatment2013 · 제45권 제3호Is Prophylactic Irradiation to Para-aortic Lymph Nodes in Locally Advanced Cervical Cancer Necessary?권상훈, 김미영, 김옥배, 김진희, 박승규, 변상준, 오영기대한암학회 · Cancer Research and Treatment2014 · 제46권 제4호Effect of Waiting Time from Pathological Diagnosis to Definitive Concurrent Chemoradiation (CCRT) for Cervical Cancer on Overall Survival박원, 김병기, 김보미, 김태중, 노경원, 배덕수, 이유영, 이정원, 조원경, 최철훈대한암학회 · Cancer Research and Treatment2022 · 제54권 제1호Radical Radiotherapy for Locally Advanced Cancer of Uterine Cervix박원, 김병기, 김태진, 박종택, 박창수, 배덕수, 심재욱, 안용찬, 이기헌, 이정은, 이제호, 임경택, 임도훈, 정환욱, 허승재대한암학회 · Cancer Research and Treatment2004 · 제36권 제4호High Dose Three-Dimensional Conformal Boost Using the Real-Time Tumor Tracking Radiotherapy System in Cervical Cancer Patients Unable to Receive Intracavitary Brachytherapy박희철, Akio Yonesaka, Hiroki Shirato, Hiroshi Taguchi, Kazuhiko Tsuchiya, Masayori Ishikawa, Noriaki Sakuragi, Norio Katoh, Rumiko Kinoshita, Shinichi Shimizu, Yasuhiko Ebina연세대학교의과대학 · Yonsei Medical Journal2010 · 제51권 제1호

이 간행물의 다른 논문 (17건)